Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Prometic Life Sciences
Prometic Life Sciences
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Design & Build
Keyplants awarded US$1m contract by Russian biotech giant Generium
KeyPlants has been awarded a conceptual design contract for the MasterPlasma fractionation facility in the Vladimir Region of Russia
Manufacturing
ProMetic signs 15-year manufacturing contract with Emergent BioSolutions
Emergent facility in Winnipeg will manufacture plasma-derived biopharmaceuticals using the ProMetic Plasma Protein Purification System (PPPS)
Research & Development
ProMetic appoints new Chief Medical Officer
Dr John Moran will take up the role on 1 March
Research & Development
ProMetic enters CAD$1.6m development deal with leading vaccines company
For the supply of an affinity resin for use in scale-up and commercial production
Manufacturing
ProMetic and Sartorius Stedim Biotech expand collaboration
To promote turnkey solution for plasma-derived therapeutics
Research & Development
ProMetic Life Sciences and NantPharma to develop plasma-derived biopharmaceuticals
NantPharma pays initial US$2.5m to ProMetic
Manufacturing
ProMetic signs agreement to improve biopharmaceutical manufacturing process
Will receive initial service revenues of CAD800,000 during 2011
Subscribe now